Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary

Emerging evidence suggests that remdesivir might improve clinical outcome of high-risk outpatients with coronavirus disease 2019 (COVID-19). Our aim was to evaluate characteristics and outcomes of nonhospitalised adults diagnosed with COVID-19 and treated with early remdesivir therapy during the omi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gáspár, Zsófia, Szabó, Bálint Gergely, Ábrahám, Anita, Várnai, Zsuzsanna, Kiss-Dala, Noémi, Szlávik, János, Sinkó, János, Vályi-Nagy, István, Lakatos, Botond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995722/
https://www.ncbi.nlm.nih.gov/pubmed/36892627
http://dx.doi.org/10.1007/s00210-023-02456-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995722/
https://www.ncbi.nlm.nih.gov/pubmed/36892627
http://dx.doi.org/10.1007/s00210-023-02456-y

Ejemplares similares